RELENZA

Product NDC
0173-0681
11-digit product format
001730681
Labeler code
0173
Product ID
0173-0681_244881b7-a19f-4409-abf7-2df6ad39c28e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
zanamivir
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Labeler
GlaxoSmithKline LLC
Application
NDA021036
Marketing category
NDA
Marketing start
1999-09-22
Substance
ZANAMIVIR
Active strength
5 mg/1
Pharmacologic classes
Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
RELENZA
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ZANAMIVIR5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiL6O3XI777I
Rxcui759471, 759473

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bf3f65a9-7280-6c6a-2c61-3b31509b45f9Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0173-0681-01RELENZA4 in 1 PACKAGEPOWDER433
0173-0681-01RELENZA5 in 1 CARTONPOWDER533
0173-0681-22RELENZA4 in 1 PACKAGEPOWDER433
0173-0681-22RELENZA5 in 1 CARTONPOWDER533

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0173-0681-01EA - Each0173-068124bd1484-71df-40c8-ac59-3085c692ea6c12012-07-24

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0173-0681RELENZA (ZANAMIVIR) POWDER [GLAXOSMITHKLINE LLC]32Current NDC, Legacy NDC, 4 package rows20240712_d7c3bcc3-0c0d-4068-fd80-88cf54a376ef.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
759473RELENZA DISKHALER 5 MG/INHAL Dry Powder Inhaler, 20 BlistersPSNd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
759471zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 BlistersPSNd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
75947320 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza]SBDd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
75947120 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder InhalerSCDd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
75947320 ACTUAT Relenza 5 MG/ACTUAT Dry Powder InhalerSYd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
759473Relenza 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUATSYd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
759471zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUATSYd7c3bcc3-0c0d-4068-fd80-88cf54a376ef33
759473RELENZA DISKHALER 5 MG/INHAL Dry Powder Inhaler, 20 BlistersPSN315556f2-4da0-47fc-86af-8fb61f6dd3bf1
759471zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 BlistersPSN315556f2-4da0-47fc-86af-8fb61f6dd3bf1
75947320 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza]SBD315556f2-4da0-47fc-86af-8fb61f6dd3bf1
75947120 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder InhalerSCD315556f2-4da0-47fc-86af-8fb61f6dd3bf1
75947320 ACTUAT Relenza 5 MG/ACTUAT Dry Powder InhalerSY315556f2-4da0-47fc-86af-8fb61f6dd3bf1
759473Relenza 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUATSY315556f2-4da0-47fc-86af-8fb61f6dd3bf1
759471zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUATSY315556f2-4da0-47fc-86af-8fb61f6dd3bf1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0173-0681-01001730681015 PACKAGE in 1 CARTON (0173-0681-01) / 4 POWDER in 1 PACKAGE5 package1999-09-220000-00-00NoNoCurrent
0173-0681-22001730681225 PACKAGE in 1 CARTON (0173-0681-22) / 4 POWDER in 1 PACKAGE5 package2007-03-09NoNoHistorical